Renal cell carcinoma, part 2.
Journal
Nursing
ISSN: 1538-8689
Titre abrégé: Nursing
Pays: United States
ID NLM: 7600137
Informations de publication
Date de publication:
01 Aug 2021
01 Aug 2021
Historique:
entrez:
4
8
2021
pubmed:
5
8
2021
medline:
12
8
2021
Statut:
ppublish
Résumé
Renal cell carcinoma (RCC) accounts for most renal malignancies. This article, the second in a three-part series, addresses how renal masses are classified, signs and symptoms of RCC, medical treatments for RCC, and priority nursing interventions for patients with RCC.
Identifiants
pubmed: 34347749
doi: 10.1097/01.NURSE.0000757136.98530.f6
pii: 00152193-202108000-00008
doi:
Types de publication
Journal Article
Langues
eng
Pagination
24-29Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Références
Pullen RL. Renal cell carcinoma, part 1. Nursing . 2021;51(7):34–41.
Bell DJ, Gaillard F, et al. Bosniak grading system of renal cystic masses. Radiopaedia. https://radiopaedia.org/articles/bosniak-classification-system-of-renal-cystic-masses?lang=us .
Reinhard R, van der Zon-Conijn M, Smithuis R. Radiology Assistant. Kidney—solid masses. https://radiologyassistant.nl/abdomen/kidney-solid-masses .
Silverman SG, Pedrosa I, Ellis JH, et al. Bosniak classification of cystic renal masses, version 2019: an update proposal and needs assessment. Radiology . 2019;292(2):475–488.
Jinzaki M, Akita H, Oya M. Imaging features of renal cell carcinoma: differential diagnosis, staging, and postreatment evaluation. In: Oya M, ed. Renal Cell Carcinoma: Molecular Features and Treatment Updates . Tokyo, Japan: Springer Japan; 2017.
Siddiqui SN, Haas CR, McKiernan JM. Epidemiology, screening, and clinical staging. In: JA Libertino JA, Gee Jr., eds. Renal Cancer: Contemporary Management . 2nd ed. Cham, Switzerland: Springer; 2020.
Mikami S, Kuroda N, Nagashima Y. Pathology of renal cell carcinoma. In: Oya M, ed. Renal Cell Carcinoma: Molecular Features and Treatment Updates . Tokyo, Japan: Springer Japan; 2017.
Afnan J, Therrien JA, Wald C. Imaging of renal cancer. In: Libertino JA, Gee JR, eds. Renal Cancer: Contemporary Management . 2nd ed. Cham, Switzerland: Springer; 2020.
Delahunt B, Eble JN, Egevad L, Samaratunga H. Grading of renal cell carcinoma. Histopathology . 2019;74(1):4–17.
National Institutes of Health. National Cancer Institute. Seer training modules. American Joint Committee on Cancer. https://training.seer.cancer.gov/staging/systems/ajcc .
Capitanio U, Montorsi F. Renal cancer. Lancet . 2016;387(10021):894–906.
Francis F, Zhou M. Pathology of renal cell carcinoma. In: Libertino Ja, Gee JR, eds. Renal Cancer: Contemporary Management . 2nd ed. Cham, Switzerland: Springer; 2020.
Henriksen KJ, Chang A. The importance of nephropathology in kidney cancer. Semin Nephrol . 2020;40(1):69–75.
American Urological Association. Renal mass and localized renal cancer: AUA guideline. 2017. www.auanet.org/guidelines/renal-cancer-renal-mass-and-localized-renal-cancer-guideline .
Palapattu GS, Kristo B, Rajfer J. Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma. Rev Urol . 2002;4(4):163–170.
Kondo T. Treatment overview. In: Oya M, ed. Renal Cell Carcinoma: Molecular Features and Treatment Updates . Tokyo, Japan: Springer Japan; 2017.
Wasserman M, Sobel D, Pareek G. Choice of surgical options in kidney cancer and surgical complications. Semin Nephrol . 2020;40(1):42–48.
Arellano RS. Ablation of renal cell carcinoma: an assessment of currently available techniques. J Radiol Nurs . 2018;37:30–33.
American Cancer Society. Cancer staging. www.cancer.org/treatment/understanding-your-diagnosis/staging.html .